The present application describes therapy with angiogenesis antagonists such as anti-VEGF antibodies. In particular, the application describes the use of such antagonists to treat autoimmune disease in a patient who has failed prior treatment such as treatment with DMARDs or TNF.alpha.-inhibitors.

 
Web www.patentalert.com

< HUMAN CYTOKINE RECEPTOR

> SIRT INHIBITORS THAT BIND TO NAD

~ 00458